Literature DB >> 23008441

Ca2+/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac disease.

Olha M Koval1, Jedidiah S Snyder, Roseanne M Wolf, Ryan E Pavlovicz, Patric Glynn, Jerry Curran, Nicholas D Leymaster, Wen Dun, Patrick J Wright, Natalia Cardona, Lan Qian, Colleen C Mitchell, Penelope A Boyden, Philip F Binkley, Chenglong Li, Mark E Anderson, Peter J Mohler, Thomas J Hund.   

Abstract

BACKGROUND: Human gene variants affecting ion channel biophysical activity and/or membrane localization are linked to potentially fatal cardiac arrhythmias. However, the mechanism for many human arrhythmia variants remains undefined despite more than a decade of investigation. Posttranslational modulation of membrane proteins is essential for normal cardiac function. Importantly, aberrant myocyte signaling has been linked to defects in cardiac ion channel posttranslational modifications and disease. We recently identified a novel pathway for posttranslational regulation of the primary cardiac voltage-gated Na(+) channel (Na(v)1.5) by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). However, a role for this pathway in cardiac disease has not been evaluated. METHODS AND
RESULTS: We evaluated the role of CaMKII-dependent phosphorylation in human genetic and acquired disease. We report an unexpected link between a short motif in the Na(v)1.5 DI-DII loop, recently shown to be critical for CaMKII-dependent phosphorylation, and Na(v)1.5 function in monogenic arrhythmia and common heart disease. Experiments in heterologous cells and primary ventricular cardiomyocytes demonstrate that the human arrhythmia susceptibility variants (A572D and Q573E) alter CaMKII-dependent regulation of Na(v)1.5, resulting in abnormal channel activity and cell excitability. In silico analysis reveals that these variants functionally mimic the phosphorylated channel, resulting in increased susceptibility to arrhythmia-triggering afterdepolarizations. Finally, we report that this same motif is aberrantly regulated in a large-animal model of acquired heart disease and in failing human myocardium.
CONCLUSIONS: We identify the mechanism for 2 human arrhythmia variants that affect Na(v)1.5 channel activity through direct effects on channel posttranslational modification. We propose that the CaMKII phosphorylation motif in the Na(v)1.5 DI-DII cytoplasmic loop is a critical nodal point for proarrhythmic changes to Na(v)1.5 in congenital and acquired cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008441      PMCID: PMC3811023          DOI: 10.1161/CIRCULATIONAHA.112.105320

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

Review 1.  The fifteen years of discoveries that shaped molecular electrophysiology: time for appraisal.

Authors:  Silvia G Priori
Journal:  Circ Res       Date:  2010-08-20       Impact factor: 17.367

Review 2.  Altered cardiac myocyte Ca regulation in heart failure.

Authors:  Donald M Bers
Journal:  Physiology (Bethesda)       Date:  2006-12

3.  Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.

Authors:  Barry London; Michael Michalec; Haider Mehdi; Xiaodong Zhu; Laurie Kerchner; Shamarendra Sanyal; Prakash C Viswanathan; Arnold E Pfahnl; Lijuan L Shang; Mohan Madhusudanan; Catherine J Baty; Stephen Lagana; Ryan Aleong; Rebecca Gutmann; Michael J Ackerman; Dennis M McNamara; Raul Weiss; Samuel C Dudley
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

4.  Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.

Authors:  Colleen E Clancy; Michihiro Tateyama; Robert S Kass
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

6.  Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites.

Authors:  Nicole M Ashpole; Anthony W Herren; Kenneth S Ginsburg; Joseph D Brogan; Derrick E Johnson; Theodore R Cummins; Donald M Bers; Andy Hudmon
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

7.  Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.

Authors:  Yejia Song; John C Shryock; Lin Wu; Luiz Belardinelli
Journal:  J Cardiovasc Pharmacol       Date:  2004-08       Impact factor: 3.105

8.  Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.

Authors:  Anne-Laure Leoni; Bruno Gavillet; Jean-Sébastien Rougier; Céline Marionneau; Vincent Probst; Solena Le Scouarnec; Jean-Jacques Schott; Sophie Demolombe; Patrick Bruneval; Christopher L H Huang; William H Colledge; Andrew A Grace; Hervé Le Marec; Arthur A Wilde; Peter J Mohler; Denis Escande; Hugues Abriel; Flavien Charpentier
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

9.  Computer model of action potential of mouse ventricular myocytes.

Authors:  Vladimir E Bondarenko; Gyula P Szigeti; Glenna C L Bett; Song-Jung Kim; Randall L Rasmusson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-13       Impact factor: 4.733

10.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

View more
  67 in total

1.  Diseases caused by mutations in Nav1.5 interacting proteins.

Authors:  John W Kyle; Jonathan C Makielski
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 2.  A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.

Authors:  Lars S Maier
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

3.  Revealing the Concealed Nature of Long-QT Type 3 Syndrome.

Authors:  Amara Greer-Short; Sharon A George; Steven Poelzing; Seth H Weinberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-02

Review 4.  Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.

Authors:  Stefan Wagner; Lars S Maier; Donald M Bers
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

5.  Dysfunction of the β2-spectrin-based pathway in human heart failure.

Authors:  Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

6.  CaMKII Phosphorylation of Na(V)1.5: Novel in Vitro Sites Identified by Mass Spectrometry and Reduced S516 Phosphorylation in Human Heart Failure.

Authors:  Anthony W Herren; Darren M Weber; Robert R Rigor; Kenneth B Margulies; Brett S Phinney; Donald M Bers
Journal:  J Proteome Res       Date:  2015-04-13       Impact factor: 4.466

Review 7.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

Review 8.  At the heart of inter- and intracellular signaling: the intercalated disc.

Authors:  Heather R Manring; Lisa E Dorn; Aidan Ex-Willey; Federica Accornero; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2018-06-06

9.  Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

Authors:  Donald M Bers; Anthony W Herren
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

10.  Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.

Authors:  Nataliya Dybkova; Stefan Wagner; Johannes Backs; Thomas J Hund; Peter J Mohler; Thomas Sowa; Viacheslav O Nikolaev; Lars S Maier
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.